Clinical pharmacology of cisplatin after intraperitoneal administration in patients with malignant ascites.
Fracasso
M E
ME
Institutes of Pharmacology, University of Verona, Italy.
Apostoli
P
P
Benoni
G
G
Bonetti
A
A
Griso
C
C
Leone
R
R
D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D019540:Area Under Curve; D001201:Ascites / Q000188:drug therapy*; D002945:Cisplatin / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D010051:Ovarian Neoplasms / Q000150:complications / Q000188:drug therapy*; D014839:Vomiting / Q000139:chemically induced
D000970:Antineoplastic Agents; D002945:Cisplatin